RETEVMO

selpercatinib · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for RETEVMO, covering 2020-05-08 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Selpercatinib and Body Composition